InspireMD Financial Statements From 2010 to 2025

NSPR Stock  USD 2.76  0.01  0.36%   
InspireMD financial statements provide useful quarterly and yearly information to potential InspireMD investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on InspireMD financial statements helps investors assess InspireMD's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting InspireMD's valuation are summarized below:
Gross Profit
1.1 M
Market Capitalization
72 M
Enterprise Value Revenue
4.8112
Revenue
6.8 M
Earnings Share
(0.71)
There are over one hundred nineteen available fundamental trends for InspireMD, which can be analyzed over time and compared to other ratios. Investors and active traders are advised to confirm InspireMD's regular fundamental performance against the performance between 2010 and 2025 to make sure the trends are evolving in the right direction. As of 01/12/2025, Market Cap is likely to grow to about 64.4 M. Also, Enterprise Value is likely to grow to about 56.8 M

InspireMD Total Revenue

3.31 Million

2.3M1.9M2.8M3.6M3.7M2.5M4.5M5.2M6.2M5.6M3.3M
Check InspireMD financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among InspireMD's main balance sheet or income statement drivers, such as Interest Expense of 23.9 K, Selling General Administrative of 8 M or Other Operating Expenses of 16.1 M, as well as many indicators such as Price To Sales Ratio of 12.01, Dividend Yield of 0.0 or PTB Ratio of 1.63. InspireMD financial statements analysis is a perfect complement when working with InspireMD Valuation or Volatility modules.
  
Check out the analysis of InspireMD Correlation against competitors.
To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide.

InspireMD Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets57.5 M54.8 M22.5 M
Slightly volatile
Other Current Liabilities2.7 M5.2 M2.9 M
Slightly volatile
Total Current Liabilities4.2 M6.9 M4.7 M
Very volatile
Cash7.6 M11.1 M8.5 M
Very volatile
Cash And Short Term Investments47.1 M44.9 M16.5 M
Slightly volatile
Common Stock Shares Outstanding29.3 M27.9 M6.1 M
Slightly volatile
Liabilities And Stockholders Equity57.5 M54.8 M21.5 M
Slightly volatile
Other Stockholder Equity315.2 M300.1 M156.2 M
Slightly volatile
Total Liabilities6.9 M9.4 M7.7 M
Slightly volatile
Total Current Assets53.3 M50.8 M20.6 M
Slightly volatile
Short and Long Term Debt Total2.7 M1.4 MM
Slightly volatile
Non Current Assets Total4.2 MM2.1 M
Slightly volatile
Non Currrent Assets Other654.2 K855.9 K809.9 K
Very volatile
Net ReceivablesM1.6 M1.3 M
Pretty Stable
Non Current Liabilities Total2.1 M1.9 M2.6 M
Slightly volatile
Inventory1.2 M1.9 M1.4 M
Pretty Stable
Property Plant And Equipment Gross5.5 M5.3 M1.7 M
Slightly volatile
Other Liabilities738.6 K1.1 M725.4 K
Slightly volatile
Property Plant And Equipment Net3.1 M2.9 M1.3 M
Slightly volatile
Current Deferred Revenue17.1 K18 K97.1 K
Slightly volatile
Accounts Payable570.7 K845.1 K712.7 K
Very volatile
Other Current Assets3.7 M3.5 M841 K
Slightly volatile
Property Plant EquipmentM2.8 M1.1 M
Slightly volatile
Long Term Debt Total939.6 K989.1 K2.3 M
Slightly volatile
Capital Surpluse157.7 M207.4 M145.5 M
Slightly volatile
Non Current Liabilities Other2.3 M2.2 M1.2 M
Slightly volatile
Deferred Long Term Asset Charges68 K76.5 K83.4 K
Slightly volatile
Warrants219.2 K246.6 K268.9 K
Slightly volatile
Net Invested Capital47.7 M45.4 M14.5 M
Slightly volatile
Net Working Capital46.1 M43.9 M14 M
Slightly volatile
Capital Lease Obligations1.5 M1.8 M1.2 M
Slightly volatile

InspireMD Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General AdministrativeM12.8 MM
Slightly volatile
Other Operating Expenses16.1 M31.5 M17.6 M
Slightly volatile
Total Operating Expenses14.4 M26.4 M14.8 M
Slightly volatile
Total Revenue3.3 M5.6 M4.1 M
Very volatile
Research Development9.6 M9.2 M4.8 M
Slightly volatile
Cost Of Revenue3.1 M5.1 MM
Slightly volatile
Selling And Marketing Expenses3.3 M4.4 MM
Pretty Stable
Non Recurring785.6 K883.8 K963.6 K
Slightly volatile
Interest Income752 K1.5 M739.7 K
Pretty Stable
Reconciled Depreciation191.7 K266.8 K182.8 K
Slightly volatile

InspireMD Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash FlowM5.3 M7.1 M
Pretty Stable
End Period Cash Flow7.2 M11.1 M7.7 M
Slightly volatile
Depreciation190.3 K266.8 K179.9 K
Slightly volatile
Stock Based Compensation2.6 MM3.7 M
Slightly volatile
Issuance Of Capital Stock27.4 M43.2 M21.9 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio12.0112.6420.772
Slightly volatile
Days Sales Outstanding129166124
Pretty Stable
Stock Based Compensation To Revenue0.830.72360.7662
Slightly volatile
Capex To Depreciation1.011.481.2378
Pretty Stable
Inventory Turnover1.91.882.2532
Pretty Stable
Days Of Inventory On Hand199201188
Slightly volatile
Payables Turnover3.754.224.4001
Pretty Stable
Sales General And Administrative To Revenue2.312.062.0923
Slightly volatile
Research And Ddevelopement To Revenue0.861.161.0481
Very volatile
Capex To Revenue0.04020.05530.0493
Slightly volatile
Cash Per Share1.761.8583.2 K
Slightly volatile
Days Payables Outstanding11089.62110
Slightly volatile
Income Quality0.590.740.7163
Slightly volatile
Current Ratio6.936.63.8276
Slightly volatile
Receivables Turnover2.62.283.0896
Pretty Stable
Graham Number5.996.3M
Slightly volatile
Capex Per Share0.01720.01814.3 K
Slightly volatile
Revenue Per Share0.280.2992.9 K
Slightly volatile
Debt To Assets0.370.260.3661
Pretty Stable
Operating Cycle328367312
Slightly volatile
Days Of Payables Outstanding11089.62110
Slightly volatile
Ebt Per Ebit1.231.081.1871
Slightly volatile
Total Debt To Capitalization0.690.360.5957
Pretty Stable
Quick Ratio6.66.293.5434
Slightly volatile
Net Income Per E B T0.80.90.9824
Slightly volatile
Cash Ratio1.461.441.8486
Very volatile
Cash Conversion Cycle218277202
Very volatile
Days Of Inventory Outstanding199201188
Slightly volatile
Days Of Sales Outstanding129166124
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio0.820.921.0006
Slightly volatile
Fixed Asset Turnover2.682.825.5621
Slightly volatile
Debt Ratio0.370.260.3661
Pretty Stable
Price Sales Ratio12.0112.6420.772
Slightly volatile
Asset Turnover0.140.150.2643
Slightly volatile

InspireMD Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap64.4 M61.4 M15.9 M
Slightly volatile

InspireMD Fundamental Market Drivers

Forward Price Earnings11.6959
Cash And Short Term Investments39 M

InspireMD Upcoming Events

4th of April 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About InspireMD Financial Statements

InspireMD shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although InspireMD investors may analyze each financial statement separately, they are all interrelated. The changes in InspireMD's assets and liabilities, for example, are also reflected in the revenues and expenses on on InspireMD's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue18 K17.1 K
Total Revenue5.6 M3.3 M
Cost Of Revenue5.1 M3.1 M
Stock Based Compensation To Revenue 0.72  0.83 
Sales General And Administrative To Revenue 2.06  2.31 
Research And Ddevelopement To Revenue 1.16  0.86 
Capex To Revenue 0.06  0.04 
Revenue Per Share 0.29  0.28 
Ebit Per Revenue(3.07)(3.22)

Pair Trading with InspireMD

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if InspireMD position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in InspireMD will appreciate offsetting losses from the drop in the long position's value.

Moving together with InspireMD Stock

  0.68EW Edwards Lifesciences CorpPairCorr
  0.73GH Guardant HealthPairCorr

Moving against InspireMD Stock

  0.57DRIO DarioHealth CorpPairCorr
  0.55VERO Venus ConceptPairCorr
  0.5VTAK Catheter PrecisionPairCorr
  0.36VNRX VolitionrxPairCorr
  0.32CI Cigna Corp Sell-off TrendPairCorr
The ability to find closely correlated positions to InspireMD could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace InspireMD when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back InspireMD - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling InspireMD to buy it.
The correlation of InspireMD is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as InspireMD moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if InspireMD moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for InspireMD can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for InspireMD Stock Analysis

When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.